(1)
Wang, X.; hui, yang; Wang, S.; Hu, X.; Yu, X.; Wang, W.; Zhang, X.; Liu, L. Comparison of Effectiveness and Safety Outcomes of Abiraterone Versus Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis: Abiraterone Versus Enzalutamide in MCRPC. J Pharm Pharm Sci 2020, 23, 451-461.